Hospital-acquired conditions declined by 13 percent between 2014 and 2017, preventing an estimated 20,500 deaths and $7.7 billion in health care costs, according to preliminary data from the Agency for Healthcare Research and Quality. HACs decreased by an estimated 910,000 over the period, including a 37 percent decline in C. difficile infections and 28 percent decline in adverse drug events, showing that patient safety initiatives such as the Hospital Improvement Innovation Networks are working to make health care safer, the agency said. AHA’s Health Research & Educational Trust leads the nation’s largest HIIN. 
 

Related News Articles

Headline
The Food and Drug Administration April 29 issued a final rule that would phase out its general enforcement discretion approach for most laboratory developed…
Headline
The Centers for Disease Control and Prevention and Food and Drug Administration are investigating adverse effects in 22 people in 11 states who received…
Headline
In clinical trials involving 220,000 patients at 59 HCA Healthcare hospitals, algorithm-driven computerized alerts helped clinicians better identify the…
Headline
Commenting April 12 on a proposed rule to strengthen oversight of accrediting organizations, AHA told the Centers for Medicare & Medicaid Services it…
Headline
The Food and Drug Administration’s proposal to regulate laboratory developed tests would undermine innovation and reduce access to effective and appropriate…
Chairperson's File
 Fostering a culture of innovation and safety that prioritizes communication and teamwork to deliver safe, world-class care to patients and also protects…